Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

FDA refuses approval of Amgen osteoporosis drug

July 17, 2017 Sales and Marketing Amgen, Evenity, Radial, UCB, biotech, drugs, osteoporosis, pharma, pharmaceutical

Amgen and its development partner UCB have announced that the FDA has issued a complete response letter for the biologics …
News
pascal_soriot

AstraZeneca’s Soriot Teva switch scotched

July 17, 2017 Medical Communications, Sales and Marketing AstraZeneca, Soriot, Teva, biotech, drugs, pharma, pharmaceutical

The rumours, beginning with a report by Israeli newspaper Calcalist, had suggested that Pascal Soriot, CEO of AstraZeneca, appeared to …
News
andrew_witty

Not long after leaving GSK, Andrew Witty dips toes back into water

July 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, G1 Therapeutics, GSK, biotech, drugs, pharma, pharmaceutical

Only a short while after leaving his position as CEO of GSK, it seems Andrew Witty cannot resist getting back …
Appointment
brexit_2

What Brexit means for drug regulation

July 14, 2017 Medical Communications, Sales and Marketing biotech, brexit, drugs, healthcare, pharma, pharmaceuticals, regulation

The pharmaceutical sector is one of the most tightly regulated industries, and most of the rules that govern the daily …
News
fda2outsideweb

FDA unanimously recommends Mylan and Biocon’s Herceptin biosimilar

July 14, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing Biocon, Herceptin, Mylan, biosimilar, biotech, drugs, healthcare, life sciences, pharma, pharmaceuticals

Mylan and Biocon have revealed that their biosimilar version of Roche and Genentech’s Herceptin (trastuzumab) has received unanimous recommendation from …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, life sciences, pharma, pharmaceutical, top ten

As the week comes to a close, we bring you the stories that were most read by our readers – …
News

J&J uses FDA Priority Review Voucher to snag psoriasis approval

July 14, 2017 Medical Communications, Sales and Marketing Janssen, Johnson & Johnson, Tremfya, biotech, drugs, pharma, pharmaceutical

The FDA has handed out another approval, as the agency now easily surpasses last year’s figure of 22 already, this …
News
wave_logo

Gain insight into what your peers are doing

July 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, life sciences, pharma, pharmaceutical, wave

When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …
News

Novartis’ breakthrough cancer treatment receives FDA advisory approval

July 13, 2017 Research and Development, Sales and Marketing CAR-T, FDA, Novartis, biotech, drugs, pharma, pharmaceutical

In what could well be a game-changing decision for cancer treatment, the FDA advisory panel gave Novartis’ CAR-T Therapy, CTL019 …
News
brexit

UK and EU life sciences demand closer collaboration in joint letter to Brexit negotiators

July 13, 2017 Sales and Marketing EU, UK, biotech, brexit, drugs, life sciences, pharma, pharmacuetical

The pharmaceutical and life sciences industries have stressed the importance of cooperation between the EU and the UK in order …
News

Enterome bolsters board with new executive appointment

July 12, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Enterome, biotech, drugs, healthcare, pharma, pharmaceuticals

Enterome, a clinical-stage company specialising in the personalised treatment of microbiome-related diseases based in Paris, France, has announced the appointment …
Appointment
francesco_maria_lavino

Nabriva Therapeutics recruit new COO

July 12, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nabriva Therapeutics, biotech, drugs, pharma, pharmaceutical

Nabriva Therapeutics, a pharmaceutical company that is developing new antibiotics for the treatment of serious infections, has brought Francesco Maria …
Appointment
teva_copy

Teva accuses ex-employee of passing company secrets to boyfriend at rival generics firm

July 12, 2017 Research and Development, Sales and Marketing Apotex, Teva, biotech, drugs, generics, healthcare, pharma, pharmaceuticals

Of all the controversy Teva has been embroiled in over the past years, the Israeli company now finds itself dogged …
News
fda2outsideweb

Plot twist as FDA U-turns on Amicus drug decision

July 11, 2017 Research and Development, Sales and Marketing Amicus Therapeutics, FDA, Galafold

The news continues to flow out of the FDA, as it grabs another headline by backtracking on its previous decision …
News

Sanofi snatches up Protein Sciences for $750 million

July 11, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, acquisition, protein sciences

French drug maker Sanofi has announced that it has agreed to acquire vaccine biotech company Protein Sciences for a potential …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026